India's pharmaceutical export landscape is preparing for a landmark event. The 12th edition of iPHEX 2026 — India's largest international pharmaceutical exhibition — is set to bring together over 600…
The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly…
India's pharmaceutical exports rose 6.8% year-on-year to reach US$ 8.1 billion in the first quarter of FY27 (April–June 2026), according to industry data reported by Indian Pharma Post and ANI…
India's pharmaceutical industry is on track to miss its ambitious 2030 export target of $130 billion, with sector leaders now projecting a revised figure of approximately $90 billion — a…